FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears
Posted on November 17, 2026
Johnson & Johnson has received U.S. Food and Drug Administration clearance for an expanded ear, nose and throat indication for its HARMONIC 1100 Shears.
The clearance enables the ultrasonic surgical device to be used across a wider range of ENT procedures in both paediatric and adult patients.
The expanded indication covers the ligation and division of vessels, lymphatics and tissue bundles.
Johnson & Johnson said HARMONIC 1100 is its first ultrasonic device with a 7 mm vessel-sealing indication for ENT surgery.
The device uses ultrasonic energy to seal and divide tissue while limiting lateral thermal spread, an important consideration in procedures involving anatomically sensitive structures.
HARMONIC 1100 is a sterile, single-patient-use device designed for applications including general dissection, vessel sealing, back-scoring, otomy creation, mesentery marching and precise tissue-plane dissection.
The device incorporates an ergonomic handle and integrated handpiece alongside Advanced Hemostasis technology.
Dual energy-delivery buttons allow surgeons to select settings intended for either focused dissection or coagulation.
Its curved and tapered blade is designed to provide access to tissue planes in confined anatomical spaces frequently encountered during ENT procedures.
Johnson & Johnson said the expanded indication was supported by real-world evidence from the Premier Healthcare Database.
The analysis showed low rates of 30-day complications and hospital readmissions when HARMONIC Shears were used in paediatric and adult ENT procedures.
Procedures included neck dissection, glossectomy, laryngectomy, pharyngectomy, tonsillectomy, parathyroid surgery, thyroidectomy and adenoidectomy.
Sandeep Makkar, Worldwide President of Endomechanical and Energy at Johnson & Johnson MedTech, said the expanded clearance increases access to HARMONIC technology across a specialty where precise tissue management is important.
The company said the expanded indication also broadens its surgical energy portfolio and supports use of ultrasonic technology across additional ENT procedures in the U.S.
Related Topics and Keywords
ENT, FDA clearance, HARMONIC 1100, HARMONIC Shears, healthcare technology, Johnson and Johnson, Johnson and Johnson MedTech, medical devices, medtech, neck dissection, otorhinolaryngology, paediatric surgery, pharma news, real-world evidence, surgical devices, surgical energy, thyroidectomy, tonsillectomy, ultrasonic surgery, vessel sealing
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















